Industry Projects
LATEST INDUSTRY PROJECTS
Stimuvax, formerly known as BLP25 liposome vaccine (L-BLP25), is an investigational therapeutic vaccine being developed to provide immunity against the cancer cells that over express Mucin 1 (MUC-1), a glycoprotein antigen.
Indinavir – First-Generation HIV Protease Inhibitor
Merck's Crixivan or indinavir sulphate is a first-generation HIV-protease inhibitor...
Merck's Crixivan or indinavir sulphate is a first-generation HIV-protease inhibitor...
Panflu.1 – Single-Shot Vaccine Against H1N1 Influenza
Developed by Sinovec Biotech to provide protection against the H1N1 virus, also known...
Developed by Sinovec Biotech to provide protection against the H1N1 virus, also known...
Novavax Trivalent VLP Vaccine for Seasonal Influenza
Novavax's trivalent seasonal influenza virus-like particle (VLP) vaccine was developed...
Novavax's trivalent seasonal influenza virus-like particle (VLP) vaccine was developed...
- Abiraterone – Prostate Cancer Therapy
- Acomplia (Rimonabant) - Investigational Agent for the Management of Obesity
- Actemra - Biological Therapy for Rheumatoid Arthritis (RA)
- Afamelanotide - Photo-Protective Drug for Treatment of Light-Related Skin Disorders
- Afinitor – Anti-Cancer Therapy
- Alemtuzumab – Potential in Multiple Sclerosis UPDATED
- Almorexant - Agent for Treatment of Sleep Disorders
- AM103 – Experimental Treatment for Respiratory Diseases
- APD125 - Therapy for Insomnia UPDATED
- Ariflo (Cilomilast) - Oral PDE-IV Inhibitor for Chronic Obstructive Pulmonary Disease (COPD)
- ASA404 Vascular Disrupting Agent for Solid Tumours
- Avastin (bevacizumab) - Angiogenesis Inhibitor and Cancer Therapy
- Caprospinol, Therapy for Alzheimer's Disease (AD)
- Ceftobiprole - Injectable Anti-MRSA Cephalosporin Antibiotic
- Celvapan – H1N1 Pandemic Influenza Vaccine
- Cerovive - Neuroprotectant for the Treatment of Acute Ischaemic Stroke
- Cervarix – Cervical Cancer Vaccine
- Cetilistat - Investigational Drug for Obesity
- Cilansetron - New Treatment for IBS UPDATED
- Elotuzumab – Anti-CS1 Antibody for Multiple Myeloma
- Enbrel – Immunosuppressant for Treatment of Rheumatoid Arthritis
- Erbitux (Cetuximab) - Biological Cancer Therapy
- ETC-216 - Phospholipid Therapy for Coronary Heart Disease (CHD) Patients
- Exanta - Oral Direct Thrombin Inhibitor for the Prevention and Treatment of Venous Thromboembolism
- Exubera - Inhaled Insulin for Type 1 and Type 2 Diabetes
- Fablyn (Lasofoxifene) - Investigational SERM for the Prevention and Treatment of Osteoporosis UPDATED
- Fampridine-SR – Treatment for Multiple Sclerosis
- Fidaxomicin – Narrow-Spectrum Antibiotic for Clostridium Difficile Infection
- Fingolimod - Novel Therapy for Multiple Sclerosis
- Florbetaben - 18F-Radiolabelled Tracer For Diagnosis of Alzheimer's Disease NEW
- Fludase - Experimental Antiviral Drug for Influenza UPDATED
- Flurizan – Anti-Amyloid Drug for Treatment of Alzheimer’s Disease
- Idraparinux - Investigational Agent for the Treatment and Prevention of Thromboembolic Events
- Iloperidone - Atypical Antipsychotic for Schizophrenia UPDATED
- INCB9471 – CCR5 Antagonist for Treatment of HIV Infection
- Indinavir – First-Generation HIV Protease Inhibitor NEW
- Influenza A (H1N1) Monovalent Vaccine by Sanofi Pasteur
- Istaroxime - Agent for Congestive Heart Failure
- Ixempra (Ixapebilone) – New Cancer Therapy
- Lexapro – Treatment for Major Depressive Disorder in Adolescents
- Licofelone - Novel Analgesic and Anti-Inflammatory Agent for Osteoarthritis
- Liraglutide - Next-Generation Antidiabetic Medication
- Lorcaserin, Investigational Oral Anti-Obesity Drug
- LY2140023 – Treatment of Schizophrenia UPDATED
- Lyrica (Pregabalin) - New Gabapentinoid with Wide Clinical Application
- M6G, A New Morphine Derivative For Post-Operative Pain Relief
- Maraviroc - Therapy for Treatment of HIV Infection
- Merck Isentress - Emerging Therapy for Treatment of HIV Infection UPDATED
- Motavizumab - New Biological Therapy for RSV Prevention
- Multaq - Investigational Agent for the Treatment of Cardiac Arrhythmia
- Mylinax - Novel Therapy for the Treatment of Multiple Sclerosis
- Pandemrix - Adjuvanted H1N1 Influenza Vaccine
- Panflu.1 – Single-Shot Vaccine Against H1N1 Influenza
- Paxil – SSRI for the Treatment of Major Depressive Disorders, USA
- Peramivir - Neuraminidase Inhibitor for Treatment of Influenza
- Pertuzumab –Cancer Therapy
- Phenserine - Next Generation AChE Inhibitor for Alzheimer's Disease (AD)
- Plectasin NZ2114 - Novel Microbial Agent
- Pradaxa – Oral Direct Thrombin Inhibitor
- Prasugrel - Investigational Antiplatelet Agent
- Prexige - COX-2 Inhibitor for the Relief of Pain and Inflammation
- Rasagiline - Second-Generation MAO-B Inhibitor for the Treatment of Parkinson's Disease
- Rasilez – Innovative Treatment for Hypertension
- Rember - Therapy for Alzheimer's Disease
- Restanza – Oral Antibiotic for Treatment of Community-Acquired Pneumonia
- Rezular – Oral Treatment for IBS
- Rupintrivir - Experimental Treatment for the Common Cold
- T-705 - Antiviral Drug for Influenza
- Tamiflu - Oral Anti-Viral Treatment Agent
- Taranabant CB1 Receptor Inverse Agonist for Obesity
- Tarceva - Small Molecule EGFR-Tyrosine Kinase Inhibitor for Cancer
- TB-402 – Therapeutic Monoclonal Antibody for VTE AND AF
- Telbivudine - Investigational Drug for Chronic Hepatitis B Infection
- Tesmilifene - Chemopotentiator for Cancer Therapies
- Tesofensine - Anti-Obesity Medication
- TRA-SCH-530348 -Oral Antiplatelet Agent
- Treximet - Next-Generation Treatment for Migraine UPDATED
- Tygacil - Broad-Spectrum Antibiotic for Empiric Treatment of Serious Infections
- Tykerb - Dual Tyrosine Kinase Inhibitor for the Treatment of Solid Tumours
- Tysabri - Therapeutic Monoclonal Antibody (MAb) for the Treatment of Multiple Sclerosis
